Skip to main content
Clinical Trials/NCT03291275
NCT03291275
Unknown
Not Applicable

Survival Outcomes of Uterine Malignancies in Chinese Population

Lei Li1 site in 1 country10,000 target enrollmentSeptember 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometrial Neoplasms
Sponsor
Lei Li
Enrollment
10000
Locations
1
Primary Endpoint
Overall survival
Last Updated
8 years ago

Overview

Brief Summary

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.

Registry
clinicaltrials.gov
Start Date
September 1, 2017
End Date
September 1, 2023
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Lei Li
Responsible Party
Sponsor Investigator
Principal Investigator

Lei Li

Professor

Peking Union Medical College Hospital

Eligibility Criteria

Inclusion Criteria

  • Primary uterine malignancies.

Exclusion Criteria

  • Metastatic malignancies to uterine corpus

Outcomes

Primary Outcomes

Overall survival

Time Frame: 5 years

Survival duration from diagnosis to death

Progression-free survival

Time Frame: 5 years

Survival duration from last treatment after remission to recurrence

Study Sites (1)

Loading locations...

Similar Trials